Friday, July 28, 2023 10:29:46 AM
Recent PROF News
- Profound Medical to Release First Quarter 2024 Financial Results on May 9 – Conference Call to Follow • GlobeNewswire Inc. • 04/22/2024 08:15:00 PM
- Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference • GlobeNewswire Inc. • 04/09/2024 11:45:00 AM
- Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/07/2024 09:05:00 PM
- Profound Medical to Participate in Barclays 26th Annual Global Healthcare Conference • GlobeNewswire Inc. • 03/04/2024 09:30:00 PM
- Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure • GlobeNewswire Inc. • 02/27/2024 12:45:00 PM
- Profound Medical to Release Fourth Quarter and Full Year 2023 Financial Results on March 7 – Conference Call to Follow • GlobeNewswire Inc. • 02/15/2024 09:30:00 PM
- Profound Medical Announces Non-Brokered Private Placement • GlobeNewswire Inc. • 01/16/2024 09:30:00 PM
- Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenues • GlobeNewswire Inc. • 01/03/2024 09:15:00 PM
- Profound Medical Announces Pricing of US$20 Million Public Offering of Common Shares • GlobeNewswire Inc. • 12/28/2023 03:40:00 AM
- Profound Medical Announces Proposed Public Offering of Common Shares • GlobeNewswire Inc. • 12/27/2023 09:15:00 PM
- Profound Medical to Participate in the Stifel 2023 Healthcare Conference • GlobeNewswire Inc. • 11/08/2023 12:45:00 PM
- Profound Medical Announces CMS Extension of Temporary ‘Code’ for TULSA to ASC Setting • GlobeNewswire Inc. • 11/03/2023 12:00:00 PM
- Profound Medical Announces Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 11/02/2023 08:05:00 PM
- Profound Medical to Release Third Quarter 2023 Financial Results on November 2 – Conference Call to Follow • GlobeNewswire Inc. • 10/19/2023 08:30:00 PM
- Profound Medical 2023 Virtual Analyst & Investor Day Agenda • GlobeNewswire Inc. • 10/10/2023 08:30:00 PM
- Profound Medical Receives U.S. FDA 510(k) Clearance for TULSA-PRO® Thermal Boost • GlobeNewswire Inc. • 09/25/2023 08:05:00 PM
- Save the Date: Profound Medical to Host Virtual Analyst & Investor Day on October 13 • GlobeNewswire Inc. • 09/21/2023 12:00:00 PM
- Profound Medical to Participate in the 2023 Cantor Global Healthcare Conference • GlobeNewswire Inc. • 09/19/2023 08:45:00 PM
- Profound Medical Announces At-the-Market Offering of up to US$30,000,000 • GlobeNewswire Inc. • 09/06/2023 11:23:52 PM
- Profound Medical Announces Second Quarter 2023 Financial Results • GlobeNewswire Inc. • 08/09/2023 08:05:00 PM
- Profound Medical to Release Second Quarter 2023 Financial Results on August 9 – Conference Call to Follow • GlobeNewswire Inc. • 08/02/2023 08:30:00 PM
- Profound Medical Announces New CPT® Category 1 Codes from the AMA for TULSA to Treat Prostate Diseases • GlobeNewswire Inc. • 06/02/2023 05:40:00 PM
- Profound Medical Announces Upcoming Investor Events • GlobeNewswire Inc. • 05/30/2023 12:00:00 PM
- Profound Medical to Participate in A.G.P.’s Virtual Healthcare Conference • GlobeNewswire Inc. • 05/18/2023 12:00:00 PM
- Profound Medical Annual and Special Meeting of Shareholders Voting Results • GlobeNewswire Inc. • 05/17/2023 08:15:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM